Caribou’s Phase I CAR-T Data In Lymphoma Show Improvement In Durability

Caribou announced updated Phase I data from the ANTLER trial of allogeneic CAR-T CB-010 in non-Hodgkin lymphomas • Source: Shutterstock

More from Clinical Trials

More from R&D